NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,897 | -21.0% | 630,413 | -13.2% | 0.00% | -20.0% |
| Q2 2023 | $35,322 | -5.1% | 725,879 | +8.3% | 0.01% | -16.7% |
| Q1 2023 | $37,204 | +73.4% | 670,084 | +25.5% | 0.01% | +100.0% |
| Q4 2022 | $21,451 | -99.9% | 534,012 | +16.7% | 0.00% | 0.0% |
| Q3 2022 | $20,044,000 | +1006.2% | 457,402 | +794.7% | 0.00% | – |
| Q2 2022 | $1,812,000 | +5.8% | 51,126 | +21.5% | 0.00% | – |
| Q1 2022 | $1,712,000 | -87.2% | 42,081 | -70.6% | 0.00% | -100.0% |
| Q4 2021 | $13,357,000 | -18.4% | 143,021 | -2.6% | 0.00% | -50.0% |
| Q3 2021 | $16,366,000 | +4.0% | 146,863 | +5.9% | 0.00% | +100.0% |
| Q2 2021 | $15,741,000 | +327.0% | 138,647 | +281.9% | 0.00% | – |
| Q1 2021 | $3,686,000 | -1.5% | 36,302 | -3.5% | 0.00% | – |
| Q4 2020 | $3,742,000 | -69.8% | 37,604 | -78.0% | 0.00% | -100.0% |
| Q3 2020 | $12,373,000 | -41.4% | 171,277 | -59.5% | 0.00% | -66.7% |
| Q2 2020 | $21,101,000 | +37.2% | 423,209 | -17.8% | 0.00% | +50.0% |
| Q1 2020 | $15,375,000 | -15.4% | 514,899 | -4.6% | 0.00% | 0.0% |
| Q4 2019 | $18,184,000 | -7.9% | 539,743 | -10.3% | 0.00% | -33.3% |
| Q3 2019 | $19,737,000 | -15.1% | 601,748 | -28.6% | 0.00% | 0.0% |
| Q2 2019 | $23,235,000 | +19.5% | 842,468 | -10.6% | 0.00% | 0.0% |
| Q1 2019 | $19,437,000 | +47.7% | 942,605 | +0.0% | 0.00% | +50.0% |
| Q4 2018 | $13,157,000 | -47.9% | 942,505 | -10.7% | 0.00% | -50.0% |
| Q3 2018 | $25,268,000 | +5845.4% | 1,055,462 | +2133.0% | 0.00% | – |
| Q4 2017 | $425,000 | -62.3% | 47,266 | -54.5% | 0.00% | – |
| Q2 2017 | $1,128,000 | -42.7% | 103,875 | -53.2% | 0.00% | – |
| Q1 2017 | $1,967,000 | -24.3% | 221,783 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $2,597,000 | +0.4% | 221,783 | -4.7% | 0.00% | 0.0% |
| Q3 2016 | $2,586,000 | -40.7% | 232,747 | -35.6% | 0.00% | 0.0% |
| Q2 2016 | $4,358,000 | – | 361,223 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |